According to the most recent statement that Quantbot Technologies LP filed with the Securities and Exchange Commission, the company increased its holdings in Treace Medical Concepts, INC (NASDAQ: TMCI) during the third quarter of this year.
The institutional investor invested approximately 417 thousand dollars in purchasing 18,933 shares of the company’s stock.
The stock of TMCI has been acquired and then disposed of by several other prominent investors. William Blair Transaction Management LLC decided to make a new investment during the second quarter, and Treace Medical Concepts was the company they chose to put their money into.
It was estimated that this investment was worth approximately $11,740,000.
RELATED: Data analytics startup Clearsense scores $50M and more digital health fundings
During the third quarter, Russell Investments Group Ltd increased its holdings in Treace Medical Concepts by investing an additional $8,334,000 to purchase additional shares of the company’s stock.
Treace Medical Concepts received an investment of approximately $4,172,000 during the second quarter from Kornitzer Capital Management INC (KS), which enabled the company to be added to the investment firm’s portfolio.
During the third quarter, Calamos Advisors LLC spent approximately $5,042,000 to purchase additional shares of Treace Medical Concepts to increase its existing stake in the company.
And finally, during the second quarter, Emerald Mutual Fund Advisers Trust increased the proportion of Treace Medical Concepts stock owned by a figure equal to 28.6%. Following the acquisition of an additional 206,686 shares during the most recent period, Emerald Mutual Fund Advisers Trust now holds a total of 929,882 shares of the company’s stock, which are currently valued at $13,335,000.
This brings the total number of shares owned by the investment adviser to 929,882. Currently, 46.17% of the company’s shares are owned by hedge funds and other institutional investors.
When trading started on Friday, the price of a share of TMCI stock was $24.47.
The stock price has a moving average of $24.07 over the past 50 days and a moving average of $22.13 over the past 200 days.
Although the current ratio is 5.66 and the quick ratio is 4.92, the debt-to-equity ratio, the current ratio, and the quick ratio all equal 0.85. Over the previous twelve months, the share price of Treace Medical Concepts, INC ranged from a low of $12.48 to a high of $26.50.
On November 8, Treace Medical Concepts (NASDAQ: TMCI) released its most recent quarterly earnings report.
The report was for the fiscal period ending in the previous quarter.
Treace Medical Concepts, INC is a company based in the United States that specializes in designing, producing, and distributing orthopedic medical devices.
These devices are primarily intended for use by foot and ankle surgeons.
It provides the Lapiplasty procedure, which enables podiatric surgeons to address all three components of the bunion and offer patients both cosmetic and therapeutic benefits as a result of the treatment.
